C-MER Medical Holdings Limited (Stock Code: 03309) published a Next Day Disclosure Return dated 24 October 2025, reporting recent changes in issued shares and treasury shares. According to the announcement, the company held 1,242,346,870 issued shares (excluding treasury shares) and 13,214,000 treasury shares as of 22 October 2025.

On 23 October 2025, the company repurchased 230,000 shares at a volume-weighted average price of HKD 1.9113, equating to approximately 0.0185% of its then-issued shares. These repurchased shares were added to treasury, bringing the treasury share count to 13,444,000 and leaving 1,242,116,870 issued shares (excluding treasury shares). The announcement also includes multiple share repurchases from July 2024 to May 2025 that are pending formal cancellation.

Under the current repurchase mandate granted on 19 May 2025, the company is authorized to repurchase up to 125,556,087 shares, with 230,000 shares repurchased on-market so far. The documents note a moratorium period on new issues or transfers of treasury shares until 22 November 2025, aligned with the relevant rules and mandate provisions.